From biopharmaceuticals to medical devices, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer and more productive lives. We have been investing globally for over 20 years across the healthcare industry: from early-stage private companies to large multinational corporations. Our team of over 60 distinguished scientific, medical, investment and other professionals manage approximately $7 billion across public and private company investments worldwide.
On the Street
Dow Jones Barron's: Top Health-Care Stocks for 2013